There are several effective antibiotics and vaccines to help combat bovine respiratory disease, or BRD, it remains an ongoing battle and costs the industry more than $1 
billion annually in the United States alone.
Bayer’s Dr. Larry Hawkins tells us about a fairly new product on the market, Zelnate® DNA Immunostimulant, a new innovation in animal health that changes the way veterinarians and producers are able to approach BRD.
Video : An overview of the impact of BRD on the cattle industry and how Zelnate® DNA Immunostimulant fits into the ongoing battle against the disease.
